These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 4877182)
1. Classification of new drug clinical evaluations. Hodges RM J Clin Pharmacol J New Drugs; 1968; 8(5):277-8. PubMed ID: 4877182 [No Abstract] [Full Text] [Related]
2. A proposed change in the classification of new drug clinical evaluations. Silson JE J Clin Pharmacol J New Drugs; 1968; 8(5):285-94. PubMed ID: 4877184 [No Abstract] [Full Text] [Related]
3. FDA's classification of new drugs. Schneiweiss F N Engl J Med; 1980 Jun; 302(24):1368-9. PubMed ID: 7374693 [No Abstract] [Full Text] [Related]
4. The FDA's classification system for new drugs. An evaluation of therapeutic gain. Finkel MJ N Engl J Med; 1980 Jan; 302(3):181-3. PubMed ID: 7350458 [No Abstract] [Full Text] [Related]
8. The FDA's new drug rating system. Ohio Med; 1991 Mar; 87(3):133-4. PubMed ID: 2030884 [No Abstract] [Full Text] [Related]
9. Classification and coding considerations for drug data base design. Forbes MB J Clin Comput; 1983; 12(3):88-100. PubMed ID: 10317426 [No Abstract] [Full Text] [Related]
10. The FDA's generic-drug approval process: similarities to and differences from brand-name drugs. Kefalas CH; Ciociola AA Am J Gastroenterol; 2011 Jun; 106(6):1018-21. PubMed ID: 21637264 [No Abstract] [Full Text] [Related]
11. Old, new, and not new drugs. Knobloch CP J Am Vet Med Assoc; 1979 Oct; 175(7):698. PubMed ID: 528312 [No Abstract] [Full Text] [Related]
12. New drugs of 2004. Hussar DA J Am Pharm Assoc (2003); 2005; 45(2):185-213; quiz 214-8. PubMed ID: 15868761 [TBL] [Abstract][Full Text] [Related]
13. FDA issues guidelines for biosimilar drugs. Cancer Discov; 2012 Mar; 2(3):196. PubMed ID: 22585973 [No Abstract] [Full Text] [Related]
14. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs. Friedman JM Teratology; 1993 Jul; 48(1):5-6. PubMed ID: 8102499 [No Abstract] [Full Text] [Related]
16. Drugs, codes, standards, and other incompatible things in the dark. Chute CG MD Comput; 2001; 18(1):45-6. PubMed ID: 11236386 [No Abstract] [Full Text] [Related]
17. Editors' note on special issue on medical product safety. Tsong Y; Chen J J Biopharm Stat; 2013; 23(1):1-2. PubMed ID: 23331217 [No Abstract] [Full Text] [Related]
18. Class labeling: FDA concepts and approach. Lewis BP Am Pharm; 1980 Feb; NS20(2):40-2. PubMed ID: 7355710 [No Abstract] [Full Text] [Related]
19. The clinical value of FDA class C drugs approved from 1981 to 1988. Yasuda SU; Woosley RL Clin Pharmacol Ther; 1992 Dec; 52(6):577-82. PubMed ID: 1458766 [No Abstract] [Full Text] [Related]
20. Understanding the FDA's guarded system for classifying new drugs. Schneiweiss F Hosp Pharm; 1979 May; 14(5):262-4, 266, 268 passim. PubMed ID: 10316828 [No Abstract] [Full Text] [Related] [Next] [New Search]